Loading...
Tactile Systems Technology Inc (TCMD) is not a strong buy at the moment for a beginner investor with a long-term focus. While the company has shown strong financial performance in the latest quarter and received an analyst upgrade with a positive price target, the technical indicators suggest a bearish trend, and there are no immediate catalysts or proprietary trading signals to support a buy decision. The options data also reflects bearish sentiment. Considering the investor's impatience and unwillingness to wait for optimal entry points, holding off on this stock for now is advisable.
The MACD is negative and expanding (-0.277), indicating a bearish trend. RSI is neutral at 24.242, and moving averages are converging, showing no clear trend. The stock is trading near its support level of 26.477, with resistance at 29.044. The short-term stock trend analysis suggests a likelihood of further decline (-1.67% next day, -2.3% next week, -4.23% next month).

Strong Q3 2025 financial performance with YoY revenue growth of 17.32%, net income growth of 59.24%, and EPS growth of 71.43%. Analyst upgrade from Piper Sandler with a price target increase to $35, citing stabilization in the lymphedema business and growth potential in Afflovest.
Technical indicators show a bearish trend. Options data reflects bearish sentiment with a high put-call volume ratio (3.33). No recent news or significant trading trends from hedge funds or insiders. Congress trading data is absent.
In Q3 2025, revenue increased to $85.76M (up 17.32% YoY), net income rose to $8.21M (up 59.24% YoY), EPS increased to 0.36 (up 71.43% YoY), and gross margin improved to 75.1% (up 1.36% YoY).
Piper Sandler upgraded TCMD to Overweight from Neutral with a price target increase from $20 to $35, citing stabilization in the lymphedema business, growth potential in Afflovest, and a favorable risk-reward profile. The firm expects a pathway back to double-digit growth in FY26 and beyond.